alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 21.0

WINN-DIXIE STORES, INC.

SUBSIDIARIES OF REGISTRANT

Winn-Dixie Stores, Inc. (the Registrant) has no parents.

The following list includes all of the subsidiaries of the Registrant as of June 28, 2006, except nine wholly-owned, inactive domestic subsidiaries of the Registrant and/or its subsidiaries.

All of the subsidiaries listed below are included in the Consolidated Financial Statements. The Consolidated Financial Statements also include the nine presently
inactive domestic subsidiaries mentioned above.

Each of the following subsidiaries is owned by the Registrant except that three subsidiaries, the names of
which are indented, are owned by the subsidiary named immediately above each indentation. All subsidiaries are wholly owned except for Bahamas Supermarkets Limited, which is owned approximately 78% by W-D (Bahamas) Limited.



|                                     |  |                       
|------------------------------------ |  | ----------------------
|Subsidiary                           |  | State of Incorporation
|Astor Products, Inc.                 |  | Florida               
|Crackin Good, Inc.                  |  | Florida               
|Deep South Products, Inc.            |  | Florida               
|Dixie Packers, Inc.                  |  | Florida               
|Dixie Stores, Inc.                   |  | New York              
|Economy Wholesale Distributors, Inc. |  | Florida               
|Superior Food Company                |  | Florida               
|Table Supply Food Stores, Inc.       |  | Florida               
|W-D (Bahamas) Limited                |  | The Bahamas           
|Bahamas Supermarkets Limited         |  | The Bahamas           
|The City Meat Markets Limited        |  | The Bahamas           
|Winn-Dixie Logistics, Inc.           |  | Florida               
|Winn-Dixie Montgomery, Inc.          |  | Florida               
|Dixie Spirits, Inc.                  |  | Mississippi           
|Winn-Dixie Procurement, Inc.         |  | Florida               
|Winn-Dixie Raleigh, Inc.             |  | Florida               
|Winn-Dixie Supermarkets, Inc.        |  | Florida               
|WIN General Insurance, Inc.          |  | South Carolina
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FORM
10-Q FOR THE SIX MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<EXCHANGE-RATE>                                      1
<CASH>                                          33,906
<SECURITIES>                                         0
<RECEIVABLES>                                   35,100
<ALLOWANCES>                                   (4,844)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                78,499
<PP&E>                                          33,059
<DEPRECIATION>                                (24,619)
<TOTAL-ASSETS>                                 160,412
<CURRENT-LIABILITIES>                           66,968
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           190
<OTHER-SE>                                      93,254
<TOTAL-LIABILITY-AND-EQUITY>                   160,412
<SALES>                                         41,751
<TOTAL-REVENUES>                                74,884
<CGS>                                            3,659
<TOTAL-COSTS>                                   62,023
<OTHER-EXPENSES>                                14,947
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  57
<INCOME-PRETAX>                                (1,601)
<INCOME-TAX>                                     2,835
<INCOME-CONTINUING>                            (2,086)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,436)
<EPS-BASIC>                                   (0.26)
<EPS-DILUTED>                                   (0.26)


</TABLE>
**ICI MUTUAL INSURANCE COMPANY  INVESTMENT COMPANY BLANKET BOND  RIDER NO. 14**

 

| **INSURED**                     |                                       | **BOND NUMBER**               |
|---------------------------------|--------------------------------------------|-------------------------------|
| **Saturna Capital Corporation** |                                       | **89265106B**                 |
| **EFFECTIVE DATE**              | **BOND PERIOD**                            | **AUTHORIZED REPRESENTATIVE** |
| **March 30, 2007**              | **November 17, 2006 to November 17, 2007** | **/s/ Maggie Sullivan**       |

  In consideration of the premium charged for this Bond, it is hereby understood  and agreed that Item 1 of the Declarations, Name of Insured, shall include the  following:  Sextant Core Fund, a series of:  Saturna Investment Trust  Except as above stated, nothing herein shall be held to alter, waive or extend  any of the terms of this Bond.

----

**ICI MUTUAL INSURANCE COMPANY  DIRECTORS AND OFFICERS/ERRORS AND OMISSIONS LIABILITY INSURANCE  ENDORSEMENT NO. 11**

| **INSURED**                     |                                       | **BOND NUMBER**               |
|---------------------------------|--------------------------------------------|-------------------------------|
| **Saturna Capital Corporation** |                                       | **89265106B**                 |
| **EFFECTIVE DATE**              | **BOND PERIOD**                            | **AUTHORIZED REPRESENTATIVE** |
| **March 30, 2007**              | **November 17, 2006 to November 17, 2007** | **/s/ Maggie Sullivan**       |

  In consideration of the premium charged for this Bond, it is hereby understood  and agreed that Item 1 of the Declarations, Named Insured Company, shall include  the following:

Sextant Core Fund, a series of:  Saturna Investment Trust  Nothing herein contained shall be held to vary, alter, waive or extend any of  the terms, conditions, provisions, agreements or limitations of this policy  other than as above stated.
ex10x12.htm


Exhibit 10.12


 







Venaxis, Inc.


 


Non-Employee Director Compensation


 



	
Type of Compensation

	
Amount


	
Monthly Cash Retainer for Non-Employee Directors

	
$  1,000


	
Stock Option Awards

	
(1)


	
Other Compensation

	
(2)












 


___________________


 



	
(1)

	
Non-employee directors typically receive a stock option award upon joining the Board, that is two times the annual grant, and then typically receive annual grants, which may be pro-rated in the first year after joining the Board.  In 2013, the annual grant was stock options to acquire 26,000 shares.







 



	
(2)

	
Directors are reimbursed for out-of-pocket expenses.
EXHIBIT 32
                                                                      ----------


   CERTIFICATION REQUIRED UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with the filing of the  financial  statements of Ophthalmic
Imaging  Systems  ("Registrant")  for the  quarter  ended  June  30,  2004  (the
"Report"),   each  of  the  undersigned  hereby  certifies,  to  such  officer's
knowledge, that:


1.   The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934, as amended, and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of Registrant.



                                             /s/ Gil Allon
                                             -------------------------
                                             Gil Allon
                                             Chief Executive Officer


                                             /s/ Ariel Shenhar
                                             ------------------------
                                             Ariel Shenhar
                                             Chief Financial Officer
#### BRANYAN et al. v. KONINKLIJKE LUCHTVAART MAATSCHAPPIJ N. V. ROYAL DUTCH AIRLINES HOLLAND. BARROWS v. KONINKLIJKE LUCHTVAART MAATSCHAPPIJ N. V. ROYAL DUTCH AIRLINES HOLLAND. GRATKE v. KONINKLIJKE LUCHTVAART MAATSCHAPPIJ N. V. ROYAL DUTCH AIRLINES HOLLAND. WERKLEY v. KONINKLIJKE LUCHTVAART MAATSCHAPPIJ N. V. ROYAL DUTCH AIRLINES HOLLAND.

United States District Court S. D. New York.

Dec. 9, 1952.

See also 11 F.R.D. 400.

*335Theodore E. Wolcott, New York City, for Werkley et al.

Walsh & Levine, New York City, for 'Gratke, Branyan & Werkley.

McLaughlin, Russel, Bullock & Lark, New York City, for Barrows.

Condon & Forsyth, New York City, for defendant.

EDELSTEIN, District Judge.

Plaintiff has moved for “an order that a commission or appropriate letters of request or other authority * * * be directed to the United States Consuls General or United States Consular Agents at Bombay, New Delhi or other appropriate cities in India and/or to the appropriate courts in India or to such persons or officers as to this Court or to' the Court in India may seem proper for oral examination and cross-examination under oath as witnesses” of several named and unnamed persons, and for the production of pertinent books, papers and records.

Rule 28(b) of the Federal Rules of Civil Procedure, 28 U.S.C.A., prescribes three methods for the taking of depositions in foreign countries: (a) on notice, (b) by commission, or (c) under letters rogatory. The extraordinarily broad language of the motion seems to ask for both a commission and letters rogatory, or for either one at the discretion of the court. There is no authority for the granting of such a shotgun motion. In view of the language of the supporting affidavit, to the effect that on information and belief it will “probably” be necessary that an application be made to the appropriate Indian Court to compel the attendance of witnesses and the production of documents, it might be understood that letters rogatory are sought. But it must clearly appear that letters rogatory are necessary or more convenient than the taking of depositions by the notice procedure or by commission, Rule 28(b); Moore’s Federal Practice, 2d Ed., vol. 4, § 28.07; which is a restatement of the long established rule that letters rogatory should not issue if the deposition may be had on notice or by commission, The Edmund Fanning, D.C., 89 F.Supp. 282. An adequate showing of necessity has not been made. The information required is readily obtainable from the State Department and the proper procedure is described and discussed in Moore, op. cit. supra, §§ 28.05, 28.06, 28.07.

Accordingly, the motion is denied, but without prejudice to a proper renewal.
Exhibit31(b)**SECTION 302 CERTIFICATION**I, Richard D. Rodekohr, certify that:1. I have reviewed this Annual Report on Form 10-K of Northwest Pipeline Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to theperiod covered by this report; 3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this report; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)), for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisreport is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and  c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the period covered by the report that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors andthe audit committee of registrant’s board of directors (or persons performing the equivalentfunctions): a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.Date: March 1, 2007     By: /s/ Richard D. Rodekohr Richard D. Rodekohr
Exhibit 31.2

CERTIFICATION OF CFO PURSUANT TO RULE 13a-14 OR 15d-14

OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION
302

OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas A. Williams, certify that:



| | 1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K of Harbinger Group Inc.;
| | -- | -----------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: January 25, 2013



/s/ THOMAS A. WILLIAMSThomas A. WilliamsExecutive Vice President and Chief Financial Officer
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 539 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 539

To amend title XVIII of the Social Security Act to repeal the Medicare 
                outpatient rehabilitation therapy caps.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 24, 2015

Mr. Cardin (for himself and Ms. Collins) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To amend title XVIII of the Social Security Act to repeal the Medicare 
                outpatient rehabilitation therapy caps.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medicare Access to Rehabilitation 
Services Act of 2015''.

SEC. 2. OUTPATIENT THERAPY CAP REPEAL.

    Section 1833 of the Social Security Act (42 U.S.C. 1395(l)) is 
amended by striking subsection (g).
                                 <all>
```
##### 



EXHIBIT 32(a) CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002 I, Charles T. Munger, Chairman of the Board (Chief Executive Officer) of Wesco Financial
Corporation (the Company), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18
U.S.C. Section 1350, that to the best of my knowledge:  (1)
    the Annual Report on Form 10-K of the Company for the year ended December 31, 2004 (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15
U.S.C. 78m or 78o(d)); and(2)
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. Dated: March 9, 2005/s/ Charles T. MungerCharles T. MungerChairman of the Board(Chief Executive Officer)
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6513

BEN FRANKLIN STATON,

Plaintiff - Appellant,

versus

JANET RENO; UNITED STATES DEPARTMENT OF

JUSTICE; U.S. BUREAU OF INVESTIGATION,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Leonie M. Brinkema, District

Judge. (CA-96-296-AM)

Submitted: June 20, 1996 Decided: July 9, 1996

Before HALL, WILKINS, and HAMILTON, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Ben Franklin Staton, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals from the district court's order denying

relief on his complaint filed under 42 U.S.C. § 1983 (1988), but

construed by the district court as a habeas corpus petition under

28 U.S.C. § 2254 (1988). We have reviewed the record and the district court's opinion and find no reversible error. Accordingly,

we affirm on the reasoning of the district court. Staton v. Reno,

No. CA-96-296-AM (E.D. Va. Mar. 7, 1996). We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

AFFIRMED
[Federal Register Volume 74, Number 142 (Monday, July 27, 2009)]
[Notices]
[Page 37039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-17833]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Clinical Trial Planning Grant.
    Date: August 13, 2009.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Kenneth E. Santora, PhD, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, 301-496-2550, <a href="/cdn-cgi/l/email-protection#046f773635326d446a6d6c2a636b72"><span class="__cf_email__" data-cfemail="462d357477702f06282f2e68212930">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-17833 Filed 7-24-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
DENMARK BANCSHARES, INC.

EXHIBIT 32.1

CERTIFICATIONS



Written Statement of the Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section1350

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Denmark Bancshares, Inc. ("DBI"), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of DBI for the quarter ended September 30, 2010, (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of DBI.



|/s/ John P. Olsen
|-----------------
|John P. Olsen,   
|President and CEO
|                 



|/s/ Dennis J. Heim               
|---------------------------------
|Dennis J. Heim                   
|Vice President, CFO and Treasurer
|                                 
|                                 
|                                 
|Date:  November 8, 2010
EXHIBIT 32.1



                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report of IntegraMed America, Inc. (the
     "Company") on Form 10-Q for the period ended March 31, 2006 as filed with
     the Securities and Exchange Commission on the date hereof (the "Report"),
     I, Jay Higham, Chief Executive Officer of the Company, certify, pursuant to
     18 U.S.C. /s/ 1350, as adopted pursuant to section 906 of the
     Sarbanes-Oxley Act of 2002, that to my knowledge:

     1.  The Report fully  complies  with the  requirements  of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     2.  The  information  contained  in  the  Report  fairly  presents,  in all
         material respects, the financial condition and results of operations of
         the Company.



                                                 /s/Jay Higham
                                                    -----------------------
                                                    Jay Higham
                                                    Chief Executive Officer
                                                    May 12, 2006